Fundz

Terrain Biosciences raised $9M in Seed funding led by Magnetic Ventures and others to advance RNA design and manufacturing for RNA-based therapies and vaccines.

PRIVATEFeb 14, 2025

Amount Raised

$9 Million

Round Type

Seed

CambridgeBiotechnologyTherapeutics

Investors

Bruker CorporationJosef FeldmanJohn MaraganoreHans BishopJohn EvansMagnetic Ventures

Description

Terrain Biosciences, based in Cambridge, MA, raised $9M in Seed funding. The company aims to utilize the funds to support RNA design and manufacturing advancements for personalized cancer vaccines and other RNA-based therapies.

Quick answer

Terrain Biosciences raised $9 Million in a Seed round, dated February 14, 2025. Investors: Bruker Corporation, Josef Feldman, John Maraganore, Hans Bishop, John Evans and Magnetic Ventures. Terrain Biosciences is based in Cambridge, Massachusetts, United States.

How much did Terrain Biosciences raise?
Terrain Biosciences raised $9 Million in a Seed round on February 14, 2025.
Who invested in Terrain Biosciences?
Bruker Corporation, Josef Feldman, John Maraganore, Hans Bishop, John Evans and Magnetic Ventures are named as investors in this round.
What does Terrain Biosciences do?
Terrain Biosciences is the world's first RNA design-build company, founded by Professors Omar Abudayyeh, Jonathan Gootenberg, and Patrick Hsu.
Where is Terrain Biosciences based and how big is it?
Terrain Biosciences is based in Cambridge, Massachusetts, United States. Fundz records about 11 employees.
Who are the decision-makers at Terrain Biosciences?
Fundz holds 1 contact at Terrain Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Terrain Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • NewcelX raised $2M (Seed) on March 28, 2025.
  • Epicrispr Biotechnologies raised $68M (Series B) on March 27, 2025.
  • Tribune Therapeutics raised $40M (Seed) on March 26, 2025.
  • Surrozen raised $76M on March 26, 2025.
  • Hillstar Bio raised $67M (Series A) on March 25, 2025.
  • Tempero Bio raised $70M (Series B) on March 24, 2025.

Who to call at Terrain Biosciences, and when

A new round usually means Terrain Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Terrain Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Terrain Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Terrain Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Terrain Biosciences

Location

Cambridge, Massachusetts, United States

About

Terrain Biosciences is the world's first RNA design-build company, founded by Professors Omar Abudayyeh, Jonathan Gootenberg, and Patrick Hsu. The company leverages advanced AI models and proprietary technologies to accelerate the development of RNA-based therapeutics and vaccines. They aim to deliver RNA design and build services 3-6 times faster than industry standards for over a dozen therapeutics companies. Terrain focuses on programmable medicines, including mRNA and gene therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Terrain Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Terrain Biosciences's next move

See what Strategic adds

Terrain Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.